Intetumumab (CNTO 95) 是一种有效的抗 EGFR 单克隆抗体,是糖工程增强抗体依赖性细胞毒性 (ADCC)。Intetumumab 可用于癌症的研究。
暂无科研文献
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer.
Shipping with dry ice.
Store at -20˚C